Congenital Adrenal Hyperplasia Landscape Research 2024: Comprehensive Insights About 8+ Pipeline Drugs Featuring Neurocrine Biosciences, Spruce Biosciences, Lundbeck, and HBM Alpha Therapeutics
Spruce Biosciences Faces Nasdaq Delisting Threat: Can a Reverse Stock Split Save Its Market Presence?
Spruce Biosciences | 10-Q: Q3 2024 Earnings Report
Spruce Biosciences | 8-K: Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
RBC Capital Sticks to Their Hold Rating for Spruce Biosciences (SPRB)
Spruce Biosciences Reports Q3 EPS (21c), Consensus (24c)
U got Fomo : They just released earnings and such during bad times in the market so they got pulled right under aswell. My mom use to work at Zebra before retiring. It’s an excellent business it’s just have to be sustained by a healthy economy